Clarifications to Measures, Analyses, and Findings in Trial of Stellate Ganglion Block Treatment for Posttraumatic Stress Disorder Symptoms | Neurology | JAMA Psychiatry | JAMA Network
[Skip to Navigation]
Views 1,446
Citations 0
Correction
July 1, 2020

Clarifications to Measures, Analyses, and Findings in Trial of Stellate Ganglion Block Treatment for Posttraumatic Stress Disorder Symptoms

JAMA Psychiatry. 2020;77(9):982. doi:10.1001/jamapsychiatry.2020.1829

In the Original Investigation, “Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial,”1 published online on November 6, 2019, and in the February 2020 issue, clarifications were needed for the measures, statistical analyses, and findings. Corrections have been made to the Abstract, Methods, Results, and Discussion sections of the text and Table 2. A new Table 3 has also been added. A letter2 explains the clarifications in detail. An earlier correction3 was made to this article. On both occasions, the article was corrected online.

References
1.
Rae Olmsted  KL, Bartoszek  M, Mulvaney  S,  et al.  Effect of stellate ganglion block treatment on posttraumatic stress disorder symptoms: a randomized clinical trial.   JAMA Psychiatry. 2019;77(2):1-9. doi:10.1001/jamapsychiatry.2019.3474PubMedGoogle Scholar
2.
Rae Olmsted  KL, Walters  BB, Wallace  D.  Questions on a randomized clinical trial of stellate ganglion block for people with posttraumatic stress disorder—reply.   JAMA Psychiatry. Published online July 1, 2020. doi:10.1001/jamapsychiatry.2019.3474 Google Scholar
3.
Rae Olmsted  KL.  Error in abstract.   JAMA Psychiatry. 2020;77(2):218. doi:10.1001/jamapsychiatry.2019.4511Google ScholarCrossref
×